DR Horton (HO2) Financial Statements
DR Horton Financial Overview
DR Horton's market cap is currently $33.68B. The company's EPS TTM is $10.15; its P/E ratio is 14.38; and it has a dividend yield of 1.20%. DR Horton is estimated to report earnings on January 19, 2027, and the estimated EPS forecast is $1.21. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 33.04B | $ 34.25B | $ 36.80B | $ 35.46B | $ 33.48B |
| Gross Profit | $ 7.36B | $ 8.12B | $ 9.54B | $ 9.35B | $ 10.50B |
| Operating Income | $ 3.61B | $ 4.42B | $ 6.11B | $ 6.24B | $ 7.71B |
| EBITDA | $ 4.02B | $ 4.84B | $ 6.37B | $ 6.41B | $ 7.71B |
| Net Income | $ 2.89B | $ 3.59B | $ 4.76B | $ 4.75B | $ 5.86B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.06B | $ 2.99B | $ 4.52B | $ 3.87B | $ 2.54B |
| Total Assets | $ 34.82B | $ 35.47B | $ 36.10B | $ 32.58B | $ 30.35B |
| Total Debt | $ 6.05B | $ 6.03B | $ 5.97B | $ 5.14B | $ 6.11B |
| Net Debt | $ 3.99B | $ 3.05B | $ 1.45B | $ 1.27B | $ 3.57B |
| Total Liabilities | $ 11.10B | $ 10.73B | $ 10.28B | $ 9.44B | $ 10.57B |
| Stockholders' Equity | $ 23.11B | $ 24.19B | $ 25.31B | $ 22.70B | $ 19.40B |
| Cash Flow | |||||
| Free Cash Flow | $ 3.35B | $ 3.28B | $ 2.02B | $ 4.16B | $ 413.60M |
| Operating Cash Flow | $ 3.51B | $ 3.42B | $ 2.19B | $ 4.30B | $ 561.80M |
| Investing Cash Flow | $ -311.80M | $ -168.70M | $ -190.60M | $ -310.20M | $ -414.90M |
| Financing Cash Flow | $ -4.11B | $ -4.76B | $ -1.36B | $ -2.67B | $ -811.20M |
Currency in USD
